Lessee, Operating Lease, Liability, to be Paid, Year Three of Rubius Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2022
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
- Summary
-
Rubius Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2018 to 31 Dec 2022.
- Rubius Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2022 was $0, a 100% decline year-over-year.
- Source SEC data
- View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)
Rubius Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -$7,601,000 | -100% | 31 Dec 2022 | 10-K | 27 Feb 2023 | 2022 | FY |
| Q4 2021 | $7,601,000 | +$211,000 | +2.9% | 31 Dec 2021 | 10-K | 25 Feb 2022 | 2021 | FY |
| Q4 2020 | $7,390,000 | +$204,000 | +2.8% | 31 Dec 2020 | 10-K | 23 Feb 2021 | 2020 | FY |
| Q4 2019 | $7,186,000 | +$18,000 | +0.25% | 31 Dec 2019 | 10-K | 12 Mar 2020 | 2019 | FY |
| Q3 2019 | $7,551,000 | 30 Sep 2019 | 10-Q | 14 Nov 2019 | 2019 | Q3 | ||
| Q2 2019 | $7,245,000 | 30 Jun 2019 | 10-Q | 13 Aug 2019 | 2019 | Q2 | ||
| Q1 2019 | $7,245,000 | 31 Mar 2019 | 10-Q | 15 May 2019 | 2019 | Q1 | ||
| Q4 2018 | $7,168,000 | 31 Dec 2018 | 10-Q | 15 May 2019 | 2019 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.